Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue

被引:87
作者
Kivisto, KT
Bookjans, G
Fromm, MF
Griese, EU
Munzel, P
Kroemer, HK
机构
[1] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL, D-7000 STUTTGART, GERMANY
[2] UNIV TUBINGEN, INST TOXICOL, D-7400 TUBINGEN, GERMANY
关键词
cytochrome P450; CYP3A; human duodenum; gastrointestinal;
D O I
10.1046/j.1365-2125.1996.42615.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The essential role of cytochrome P450 3A4 (CYP3A4) in human small intestine is well established, and CYP3A5 seems also to be present in most subjects. However, the role of CYP3A7 in the small intestine remains poorly characterized. We have therefore studied the expression of these CYP3A enzymes in the duodenal tissue from 19 patients, using a specific RT-PCR (reverse transcriptase-polymerase chain reaction) method. CYP3A4 and CYP3A5 were present at the mRNA level in the duodenum of 18 and 19 of the 19 patients studied, respectively. In contrast, mRNA for CYP3A7 was not found in the duodenum in any of the patients. These findings strongly suggest that, unlike CYP3A4 and CYP3A5, CYP3A7 is not expressed in human duodenum.
引用
收藏
页码:387 / 389
页数:3
相关论文
共 24 条
  • [1] AOYAMA T, 1989, J BIOL CHEM, V264, P10388
  • [2] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [3] DEWAZIERS I, 1990, J PHARMACOL EXP THER, V253, P387
  • [4] DISPOSITION OF INTRAVENOUS AND ORAL CYCLOSPORINE AFTER ADMINISTRATION WITH GRAPEFRUIT JUICE
    DUCHARME, MP
    WARBASSE, LH
    EDWARDS, DJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (05) : 485 - 491
  • [5] FROMM MF, 1995, N-S ARCH PHARMACOL S, V351, P2
  • [6] PHARMACOGENETIC PHENOTYPING AND GENOTYPING - PRESENT STATUS AND FUTURE POTENTIAL
    GONZALEZ, FJ
    IDLE, JR
    [J]. CLINICAL PHARMACOKINETICS, 1994, 26 (01) : 59 - 70
  • [7] GORSKI JC, 1994, BIOCHEM PHARMACOL, V47, P1643
  • [8] CYCLOSPORIN-ERYTHROMYCIN INTERACTION IN RENAL-TRANSPLANT PATIENTS
    GUPTA, SK
    BAKRAN, A
    JOHNSON, RWG
    ROWLAND, M
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (04) : 475 - 481
  • [9] EXPRESSION OF XENOBIOTIC-METABOLIZING CYTOCHROME-P450 FORMS IN HUMAN ADULT AND FETAL LIVER
    HAKKOLA, J
    PASANEN, M
    PURKUNEN, R
    SAARIKOSKI, S
    PELKONEN, O
    MAENPAA, J
    RANE, A
    RAUNIO, H
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (01) : 59 - 64
  • [10] BIOAVAILABILITY OF CYCLOSPORINE WITH CONCOMITANT RIFAMPIN ADMINISTRATION IS MARKEDLY LESS THAN PREDICTED BY HEPATIC ENZYME-INDUCTION
    HEBERT, MF
    ROBERTS, JP
    PRUEKSARITANONT, T
    BENET, LZ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (05) : 453 - 457